Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Cells
|
April 30, 2021
Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer
Fabrizio Marcucci, Cristiano Rumio
Cells
|
March 25, 2022
Tumor Cell Glycolysis-At the Crossroad of Epithelial-Mesenchymal Transition and Autophagy
Fabrizio Marcucci, Cristiano Rumio
Discovery Medicine
|
June 26, 2024
The Role of Oxidative Metabolism in Tumorigenesis and Drug Resistance
Fabrizio Marcucci, Cristiano Rumio
Cellular and Molecular Life Sciences : CMLS
|
September 17, 2020
The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?
Fabrizio Marcucci, Cristiano Rumio
Cells
|
May 16, 2023
On the Role of Glycolysis in Early Tumorigenesis-Permissive and Executioner Effects
Fabrizio Marcucci, Cristiano Rumio
Neoplasia (New York, N.Y.)
|
January 8, 2021
Glycolysis-induced drug resistance in tumors-A response to danger signals?
Fabrizio Marcucci, Cristiano Rumio
Journal of Thoracic Disease
|
March 14, 2019
From "high" ZEB1 to "low" B-cell lymphoma 2-interacting mediator of cell death (BIM)-an epithelial-mesenchymal transition (EMT)-associated drug resistance pathway elucidated
Fabrizio Marcucci, Cristiano Rumio
Frontiers in Pharmacology
|
July 18, 2018
How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications
Fabrizio Marcucci, Cristiano Rumio
Biochimica Et Biophysica Acta. Reviews on Cancer
|
October 24, 2017
Tumor cell-associated immune checkpoint molecules - Drivers of malignancy and stemness
Fabrizio Marcucci, Cristiano Rumio, Angelo Corti
Frontiers in Oncology
|
June 1, 2016
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal
Fabrizio Marcucci, Cristiano Rumio, François Lefoulon
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Cells
|
April 30, 2021
Depleting Tumor Cells Expressing Immune Checkpoint Ligands-A New Approach to Combat Cancer
Fabrizio Marcucci, Cristiano Rumio
Cells
|
March 25, 2022
Tumor Cell Glycolysis-At the Crossroad of Epithelial-Mesenchymal Transition and Autophagy
Fabrizio Marcucci, Cristiano Rumio
Discovery Medicine
|
June 26, 2024
The Role of Oxidative Metabolism in Tumorigenesis and Drug Resistance
Fabrizio Marcucci, Cristiano Rumio
Cellular and Molecular Life Sciences : CMLS
|
September 17, 2020
The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?
Fabrizio Marcucci, Cristiano Rumio
Cells
|
May 16, 2023
On the Role of Glycolysis in Early Tumorigenesis-Permissive and Executioner Effects
Fabrizio Marcucci, Cristiano Rumio
Neoplasia (New York, N.Y.)
|
January 8, 2021
Glycolysis-induced drug resistance in tumors-A response to danger signals?
Fabrizio Marcucci, Cristiano Rumio
Journal of Thoracic Disease
|
March 14, 2019
From "high" ZEB1 to "low" B-cell lymphoma 2-interacting mediator of cell death (BIM)-an epithelial-mesenchymal transition (EMT)-associated drug resistance pathway elucidated
Fabrizio Marcucci, Cristiano Rumio
Frontiers in Pharmacology
|
July 18, 2018
How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications
Fabrizio Marcucci, Cristiano Rumio
Biochimica Et Biophysica Acta. Reviews on Cancer
|
October 24, 2017
Tumor cell-associated immune checkpoint molecules - Drivers of malignancy and stemness
Fabrizio Marcucci, Cristiano Rumio, Angelo Corti
Frontiers in Oncology
|
June 1, 2016
Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal
Fabrizio Marcucci, Cristiano Rumio, François Lefoulon
Page
of 7